Prostaglandins for preventing postpartum haemorrhage

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Gülmezoglu, A Metin ^a   Forna, F ^b   Villar, J ^b   Hofmeyr, G J ^b  

^a WORLD BANK   (United States)

^b NONE

Author keywords

*Labor stage, third; Misoprostol adverse effects; *therapeutic use ; Oxytocics adverse effects; *therapeutic use ; Postpartum hemorrhage *prevention control ; Prostaglandins therapeutic use

Indexed keywords

CARBOPROST TROMETAMOL; ERGOMETRINE; ERGOMETRINE PLUS OXYTOCIN; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN F2 ALPHA; SULPROSTONE; UTEROTONIC AGENT;

ABDOMINAL PAIN; BLOOD TRANSFUSION; CLINICAL TRIAL; DIARRHEA; DRUG EFFECT; FEMALE; FEVER; HEADACHE; HUMAN; LABOR STAGE 3; MATERNAL MORBIDITY; MATERNAL MORTALITY; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; REVIEW; SHIVERING; SYSTEMATIC REVIEW; VOMITING;

EID: 44949203641     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000494.pub3     Document Type: Review

References (122)

1. Australia 1999 {published data only} Cook C, Spurrett B, Murray H. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour. Australian and New Zealand Journal of Obstetrics and Gynaecology 1999;39(4):414-9.
2. Belgium 1999 {published data only} Amant F, Spitz B, Timmerman D, Corremans A, Van Assche FA. Misoprostol compared with methylergometrine for the prevention of postpartumhaemorrhage: a double-blind randomised trial. British Journal of Obstetrics and Gynaecology 1999;106:1066-70.
3. Canada 2002 {published data only} Karkanis S, Caloia D, Salenieks M, Kingdom J, Walker M, Meffe F, et al. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. Journal of Obstetrics & Gynaecology of Canada: JOGC 2002;24(2):149-54.
4. Canada 2005 {published and unpublished data} Baskett TF, Persad V, Clough H, Young D. Prophylactic use of misoprostol in the third stage of labor [abstract]. Obstetrics & Gynecology 2005;105(4 Suppl):39S.
5. China 2004a {published data only} Lam H, Tang OS, Lee CP, Ho PC. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstetricia et Gynecologica Scandinavica 2004;83:647-50.
6. Colombia 2002 {published data only} Penaranda W, Arrieta O, Yances B. Active management of the childbirth with sublingual misoprostol: a clinical controlled trial in the Hospital de Maternidad Rafael Calvo [Manejo activo del alumbramiento conmisoprostol sublingual: un estudio clinico controlado en el Hospital de Maternidad Rafael Calvo de Cartagena]. Revista Colombiana de Obstetricia y Ginecologia 2002;53(1):87-92.
7. Egypt 1993 {published data only} Abdel-Aleem H, Abol-Oyoun EM, Moustafa SAM, Kamel HS, Abdel-Wahab HA. Carboprost trometamol in the management of the third stage of labor. International Journal of Gynecology & Obstetrics 1993;42:247-50.
8. Egypt 1997 {unpublished data only} Abdel-Aleem H, Mostafa SAM, Makarem MH, Abol-Oyoun EM, Shoukry M. Management of the third stage of labour with carboprost trometamol in high risk patients for postpartum hemorrhage. Assiut Medical Journal 1994;18:15.
9. *Abdel-Aleem H, Mostafa SAM, Makarem MH, Abol-Oyoun EM, Shoukry M. Management of the third stage of labour with carboprost trometamol in high risk patients for postpartum hemorrhage. The First World Congress on Maternal Mortality; 1997 March 8-14; Morocco. 1997.
10. France 2001 {published data only} Benchimol M, Gondry J, Mention J, Gagneur O, Boulanger J. Role of misoprostol in controlled delivery [Place du misoprostol dans la direction de la delivrance]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 2001;30(6): 576-83.
11. Gambia 2005 {published data only} Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, Sloan N. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2005;112(9):1277-83.
12. Ghana 2000 {published data only} Walley RL, Wilson JB, Crane JM, Matthews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG: an international journal of obstetrics and gynaecology 2000;107(9):1111-5.
13. Ghana 2006 {published data only} Parsons S, Ntumy YM, Walley RL, Wilson JB, Crane JMG, Matthews K, et al. Rectal misoprostol vs intramuscular oxytocin in the routine management of the third stage of labour. 30th British Congress of Obstetrics and Gynaecology; 2004 July 7-9 Glasgow, UK. 2004:18.
14. *Parsons S, Walley RL, Crane JMG, Matthews K, Hutchens D. Oral misoprostol versus oxytocin in the management of the third stage of labour. Journal of Obstetrics & Gynaecology of Canada: JOGC 2006;28:20-26.
15. Guinea-Bissau 2005 {published data only} *Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005;331(7519):723.
16. Nielsen BB, Hoj L, Hvidman LE, Nielsen J, Cardoso P, Aaby P. Reduced post-partum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country - secondary publication. Ugeskrift for Laeger 2006;168(13):1341-3.
17. Holland 1991 {published data only} *Poeschmann RP, Doesburg WH, Eskes TKAB. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. British Journal of Obstetrics and Gynaecology 1991;98:528-30.
18. Poeschmann RP, Eskes TKAB, Doesburg WH. Oxytocin and sulprostone reduce postpartum blood los and shorten the third stage in low risk term women. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 Sept 15-20; Singapore. 1991:312.
19. Poeschmann RP, Eskes TKAB, Doesburg WH, Lemmens WAJG, Benneker JCLH. Oxytocin and sulprostone reduce postpartumblood loss in low risk term women compared to saline. Proceedings of the 1st European Congress on Prostaglandins in Reproduction (ECPR); 1988 July 6-9; Vienna, Austria. 1988:176.
20. Holland 1995 {published data only} Van Selm M, Kanhai HHH, Keirse MJNC. Preventing the recurrence of atonic postpartum hemorrhage: a double blind trial. Acta Obstetricia et Gynecologica Scandinavica 1995;74:270-4.
21. Hong Kong 2001 {published data only} *Ng PS, Chan ASM, Sin WK, Tang LCH, Cheung KB, Yuen PM. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour. Human Reproduction 2001;16(1):31-5.
22. Ng PS, Chan ASM, Sin WK, Tang LCH, Cheung KB, Yuen PM. Comparison of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor amulticenter randomised controlled trial. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3-8; Washington DC, USA. 2000; Vol. 4:29.
23. India 1988c {published data only} Bhattacharya P, Devi PK, Jain S, Kanthamani CR, Raghavan KS. Prophylactic use of 15(S)15 methyl PGF2alpha by intramuscular route for control of postpartum bleeding - a comparative trial with methylergometrine. Acta Obstetricia et Gynecologica Scandinavica Supplement 1988;145:13-5.
24. India 2001b {published data only} Reddy R, Shenoy JV. Active management of third stage of labour. A comparative study in high risk patients for atonic postpartum haemorrhage. Journal of Obstetrics and Gynecology of India 2001;51(2):44-7.
25. India 2004b {published data only} Vimala N, Mittal S, Kumar S, Dadhwal V, Mehta S. Sublingual misoprostol versusmethlergometrine for activemanagement of third stage of labor. International Journal of Gynecology & Obstetrics 2004;87:1-5.
26. India 2005a {published data only} Garg P, Batra S, Gandhi G. Oral misoprostol versus injectable methyergometrine inmanagement of the third stage of labour. International Journal of Gynecology & Obstetrics 2005;91:160-1.
27. India 2006a {published data only} Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. International Journal of Gynecology & Obstetrics 2006;92:106-10.
28. India 2006b {published data only} Zachariah ES, Naidu M, Seshadri L. Oral misoprostol in the third stage of labour. International Journal of Gynecology & Obstetrics 2006;92:23-6.
29. India 2006c {unpublished data only} Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al.Oral misoprostol in preventing postpartum hemorrhage in a community setting. International Conference. Evidence-based interventions to prevent postpartumhaemorrhage: translating research into practice; 2006 July 13-14; Goa, India. 2006.
30. *Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al.Oral misoprostol in preventing postpartum hemorrhage in a community setting. Lancet 2006 in press.
31. Geller SE, Patel A, Niak VA, Goudar SS, Edlavitch SA, Kodkany BS, et al.Conducting international collaborative research in developing nations. International Journal of Gynecology & Obstetrics 2004;87(3): 267-71.
32. Kodkany BS, Derman RJ, Goudar SS, Geller SE, Edlavitch SA, Naik VA, et al.Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India. International Journal of Fertility & Womens Medicine 2004;49(2):91-6.
33. India 2006d {published data only} Nellore V, Mittal S, Dadhwal V. Rectal misoprostol vs. 15-methyl prostaglandin F2-alpha for the prevention of postpartum hemorrhage. International Journal of Gynecology & Obstetrics 2006;94:45-6.
34. Mozambique 2001 {published data only} Bugalho A, Daniel A, Faundes A, Cunha M. Misoprostol for prevention of postpartum haemorrhage. International Journal of Gynecology & Obstetrics 2001;73:1-6.
35. Nigeria 2003 {published data only} Oboro VO, Tabowei TO. A randomised controlled trial ofmisoprostol versus oxytocin in the active management of the third stage of labour. Journal of Obstetrics and Gynaecology 2003;23:13-6.
36. Singapore 1995 {published data only} Chua S, Chew SL, Yeoh CL, Roy AC, Ho LM, Selamat N, et al.A randomized controlled study of prostaglandin 15-methyl F2alpha compared with syntometrine for prophylactic use in the third stage of labour. Australian and New Zealand Journal of Obstetrics and Gynaecology 1995;35(4):413-6.
37. South Africa 1998a {published data only} Bamigboye AA, Merrell DA, Hofmeyr GJ, Mitchell R. Randomized comparison of rectalmisoprostol with syntometrine formanagement of third stage of labor. Acta Obstetricia et Gynaecologica Scandinavica 1998;77:178-81.
38. South Africa 1998b {published data only} Hofmeyr GJ, de Jager M, Rose L, Nikodem VC, Lawrie T. Misoprostol for third stage of labour management: a double blind, placebo controlled clinical trial. Proceedings of the 16th Conference on Priorities in Perinatal Care in South Africa; 1997; South Africa. 1997:29-31.
39. *Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oralmisoprostol in the third stage of labour. British Journal of Obstetrics and Gynaecology 1998;105:971-5.
40. South Africa 1998c {published data only} Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartum haemorrhage: a placebo controlled trial. Proceedings of the 17th Conference on Priorities in Perinatal Care in South Africa; 1998; South Africa. 1998:49-52.
41. *Bamigboye AA, Hofmeyr GJ, Merrell DA. Rectal misoprostol in the prevention of postpartumhemorrhage: a placebo-controlled trial. American Journal of Obstetrics and Gynecology 1998;179(4):1043-6.
42. South Africa 1998d {published and unpublished data} Hofmeyr GJ, Nikodem C, de Jager M, Drakely A, Gilbart B. Oral misoprostol for labour third stage management: randomised assessment of side effects (part 2). Proceedings of the 17th Conference on Priorities in Perinatal Care; 1988; South Africa. 1998:53-4.
43. South Africa 2001 {published and unpublished data} Hofmeyr G, Nikodem V, De Jager M, Drakely A. Side effects of oral misoprostol in the third stage of labour: a random allocation placebo controlled trial. Journal of Obstetrics and Gynaecology 2000;20(Suppl 1):S40-S41.
44. Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A. Oral misoprostol for labour third stage management: randomised assessment of side effects (part 1). Proceedings of the 17th Conference on Priorities in Perinatal Care; 1998; South Africa. 1998:53-4.
45. *Hofmeyr GJ, Nikodem VC, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour: a randomised placebo controlled trial. South African Medical Journal 2001;91(5):432-5.
46. Switzerland 1999 {published data only} *Surbek DV, Fehr P, Hoesli I, Holzgreve W. Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. Obstetrics & Gynecology 1999;94:255-8.
47. Surbek DV, Fehr PM, Hoesli I, Holzgreve W. Oral misoprostol vs placebo for third stage of labor [Orales misoprostol reduziert den postpartalen blutverlust]. Gynakologisch Geburtshilfliche Rundschau 1999;39:144.
48. Turkey 2002 {published data only} Caliskan E, Meydanli M, Dilbaz B, Aykan B, Sonmezer M, Haberal A. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. American Journal of Obstetrics and Gynecology 2002;187:1038-45.
49. Turkey 2003 {published data only} Caliskan E, Dilbaz B, Meydanli M, Ozturk N, Narin M, Haberal A. Oralmisoprostol for the third stage of labor: a randomized controlled trial. Obstetrics & Gynecology 2003;101:921-8.
50. United Kingdom 1994 {published data only} Chou MM, MacKenzie IZ. A prospective, double blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. American Journal of Obstetrics and Gynecology 1994;171:1356-60.
51. United Kingdom 2000 {unpublished data only} El-Refaey H, Nooh R, O'Brien P, Abdalla M, Geary M, Walder J, et al.The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG: an international journal of obstetrics and gynaecology 2000;107:1104-10.
52. United Kingdom 2001b {published data only} *Lokugamage A, Paine M, Bassaw-Balroop K, Sullivan K, el-Refaey H, Rodeck C. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon. Australian and New Zealand Journal of Obstetrics and Gynaecology 2001;41(4):411-4.
53. Lokugamage A, Paine M, Bassaw-Balroop K, Sullivan K, el-Refaey H, Rodeck C. Active management of the third stage at caesarean section: misoprostol vs syntocinon. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3-8; Washington DC, USA (Book 2). 2000:54.
54. United Kingdom 2003 {published data only} Khan R, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administeredmisoprostol in the third stage of labor. Obstetrics & Gynecology 2003;101(5):968-974.
55. USA 1990 {published data only} Catanzarite VA. Prophylactic intramyometrial carboprost tromethamine does not substantially reduce blood loss relative to intramyometrial oxytocin at routine cesarean section. American Journal of Perinatology 1990;7:39-42.
56. USA 2001 {published data only} Gerstenfeld TS, Wing DA. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. American Journal of Obstetrics and Gynecology 2001;185:878-82.
57. USA 2004 {published data only} Bhullar A, Carlan SJ, Hamm J, Lamberty N, White L, Richichi K. Buccal misoprostol to decrease blood loss after vaginal delivery: a randomized trial. Obstetrics & Gynecology 2004;104(6):1282-8.
58. USA 2005 {published data only} Hamm J, Russell Z, Botha T, Carlan SJ, Richichi K. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study. American Journal of Obstetrics and Gynecology 2005;192:1404-6.
59. WHO 1999 {published and unpublished data} Lumbiganon P, Hofmeyr J, Gülmezoglu AM, Pinol A, Villar J. Misoprostol dose-related shivering and pyrexia in the third stage of labour. British Journal of Obstetrics and Gynaecology 1999;106:304-8.
60. WHO 2001 {published and unpublished data} *Gülmezoglu AM, Villar J, Ngoc NN, Piaggio G, Carroli G, Adetoro L, et al.The WHO multicentre double-blind randomized controlled trial to evaluate the use of misoprostol in the management of the third stage of labour. Lancet 2001;358(9283):689-95.
61. Lumbiganon P, Villar J, Piaggio G, Gülmezoglu AM, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour. BJOG: an international journal of obstetrics and gynaecology 2002;109:1222-6.
62. Zimbabwe 2001 {published data only} Kundodyiwa TW, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. International Journal of Gynecology & Obstetrics 2001;75:235- 41.
63. Austria 1983 Baumgarten K, Schmidt J, Horvat A, Neumann M, Cerwenka R, Gruber W, et al.Uterine motility after post-partum application of sulprostone and other oxytocics. European Journal of Obstetrics & Gynecology and Reproductive Biology 1983;16:181-92.
64. Canada 2004 Chandra S, Persad V, Young D, Baskett T. A preliminary study of cutaneous blood flow associated with postpartum use of oral misoprostol. Journal of Obstetrics & Gynaecology Canada: JOGC 2004;26(12):1073-6.
65. China 1997 Liu C, Wang D, Li X, Yuxia Y, Jian Z, Tao L. Clinical study on reduction of postpartum bleeding by methyl carprost suppository. Chinese Journal of Obstetrics and Gynecology 1997;32(1):22-4.
66. China 1998 Zhao Y, Li X, Peng Y. Clinical study on reduction of postpartum bleeding in cesarean section by misoprostol. Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics and Gynecology) 1998;33(7): 403-5.
67. China 1998b Weihong H, Hanrong L, Linan C. Preventing of postpartum haemorrhage by Carboprost Methylate suppository administered through vagina or sublingually. Acta Academiae Medicinae Shangai 1998;25(2):137-139.
68. China 2001 Jiang Q, Wang P, Cao W. Effect on different doses of misoprostol to prevent postpartum hemorrhage. Chinese Nursing Research 2001;15(6):313-14.
69. China 2004b Ng PS, Yuen PM, Sahota DS. Comparison of oral misoprostol and intravascular syntocinon in the management of the third stage of labour - a double-blind randomised controlled trial. 30th British Congress of Obstetrics and Gynaecology; 2004 July 7-9 Glasgow, UK. 2004:69.
70. China 2004c Yuen PM, Ng PS, Sahota DS. A double-blind randomised controlled trial of oral misoprostol in addition to intra-muscular syntometrine in themanagement of the third stage of labour. 30th British Congress of Obstetrics and Gynaecology; 2004 July 7-9 Glasgow, UK. 2004:62.
71. Egypt 1999 Diab KM, Ramy AR, Yehia MA. The use of rectal misoprostol as active pharmacological management of the third stage of labor. Journal of Obstetrics and Gynaecology Research 1999;25(5):327-32.
72. Hungary 1979 Kerekes L, Domokos N. The effect of prostaglandin F2alpha on third stage of labour. Prostaglandins 1979;18:161-6.
73. India 1988a Devi PK, Sutaria UD, Raghavan KS. Prophylactic use of 15(S)15 methyl PGF2alpha for control of postpartum bleeding. Acta Obstetricia et Gynaecologica Scandinavica Supplement 1988;145:7-8.
74. India 1988b Anjaneyulu R, Devi PK, Jain S, Kanthamani CR, Vijaya R, Raghavan KS. Prophylactic use of 15(S)15 methyl PGF2alpha by intramuscular route - a controlled clinical trial. Acta Obstetricia et Gynecologica Scandinavica Supplement 1988;145:9-11.
75. India 2000a Chatterjee A. Misoprostol and the third stage. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3-8; Washington DC, USA. 2000; Vol. 4:29.
76. India 2000b Dutta DK, Saha KK. Comparative study on role of syntometrine and prostaglandin in the prevention of PPH. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3-8; Washington DC, USA. 2000; Vol. 4:29.
77. India 2000c Rajwani J, Survana K. Active management of third stage of labor - a comparative study. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3-8; Washington DC, USA (Book 4). 2000:54.
78. India 2001a Ray A, Mukherjee P, Basu G, Chatterjee A. Misoprostol and third stage of labour. Journal of Obstetrics and Gynecology of India 2001;51(6):53-4.
79. India 2005b Singh N, Singh U. Methylergometrine and carboprost tromethamine prophylaxis for postpartum hemorrhage. Journal of Obstetrics and Gynaecology of India 2005;55(4):325-8.
80. India 2006e Chandhiok N, Dhillon BS, Datey S, Mathur A, Saxena NC. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. International Journal of Gynecology & Obstetrics 2006;92:170-5.
81. Indonesia 2002 Dasuki D, Emilia O, Harini S. Randomized clinical trial: the effectiveness of oral misoprostol versus oxytocin in prevention of postpartum hemorrhage [abstract]. Journal of Obstetrics and Gynaecology Research 2002;28(1):46.
82. Israel 1992 Bider D, Ben-Rafael Z, Dulitzky M, Menashe Y, Mashiach S, Barkai G. Effect of intraumbilical prostaglandin F2alpha injection on the third stage of labour. Journal of Reproductive Medicine 1992;37:317-9.
83. Italy 1988 Norchi S, Beretta E, Zanini A, Bottino S. Prevention of primary postpartum haemorrhage (PPH). Controlled clinical trial: sulprostone vs metilergometrina. World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil. 1988.
84. Japan 1976 Takagi S, Yoshida T, Togo Y, Tochigi H, Abe M, Sakata H, et al.The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage. Prostaglandins 1976;12:565-79.
85. Singapore 1990 Ilancheran A, Ratnam SS. Effects of oxytocics on prostaglandin levels in the third stage of labour. Gynecologic and Obstetric Investigation 1990;29:177-80.
86. Singapore 2001 Chong YS, Chua S, El-Refaey H, Choo WL, Boonsri C, Koh BC, et al.Can oral misoprostol be used as an alternative to parenteral oxytocics in the active management of the third stage of labour? A preliminary study of its effect on the postpartum uterus. Personal Communication 1997.
87. Chong YS, Chua S, El-Refaey H, Choo WL, Chanrachakul B, Tai BC, et al.Postpartum intrauterine pressure studies of the uterotonic effect of oralmisoprostol and intramuscular syntometrine. BJOG: an international journal of obstetrics and gynaecology 2001;108:41-7.
88. South Africa 1999 Lokugamage AU, Moodley J, Sullivan K, Rodeck CH, Niculescu L, Tigere P. The Durham primary postpartum haemorrhage study. Women's Health - into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town, South Africa. 1999:77-8.
89. *Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El-Refaey H, Moodley J, Rodeck CH. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstetrica et Gynecologica Scandinavica 2001;80:835-39.
90. Turkey 2005 Ozkaya O, Sezik M, Kaya H, Desdicioglu R, Dittrich R. Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage. Journal of Obstetrics and Gynaecology Research 2005;31:389-93.
91. United Kingdom 2001a Acharya G, Al-Sammarai M, Patel N, Al-Habib, Kiserud T. A randomised, controlled trial comparing effect of oralmisoprostol and intravenous syntocinon on intra-operative blood loss during caesarean section. Acta Obstetrcia et Gynecologica Scandinavica 2001;80:245-50.
92. USA 1983 Nelson GH. Use of 15-Methyl prostaglandin F2alpha postpartum to contract the uterus in normal pregnant women. Journal of the Medical Association of Georgia 1983;72:703-6.
93. USA 1999 Daly S, Andolina K, Tolosa JE, Roberts N, Wapner R. A randomized controlled trial ofmisoprostol versus oxytocin in preventing postpartum blood loss. American Journal of Obstetrics and Gynecology 1999;180:S68.
94. Fu 2003 Fu YX, Ran KQ, Wang M. Prevention of early postpartum hemorrhage by way of oral misoprostol. Journal of Nursing Science 2003;18(12):910-1.
95. Kushtagi 2006 Kushtagi P, Verghese LM. Evaluation of two uterotonic medications for the management of the third stage of labor. International Journal of Gynecology & Obstetrics 2006;94(1): 47-8.
96. Lapaire 2006 Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery. International Journal of Gynecology & Obstetrics 2006;95(1):2-7.
97. Li 2003 Li D, Bei HZ. Clinical study on reduction of postpartum bleeding in the risk factors by misoprostol. Hainan Medical Journal 2003;14(11):11-2.
98. Nagaria 2006 Nagaria T, Ekka M. Intramuscular PGF2 a 125 microg versus intravenous methyl ergometrine 0.2mg in the active management of third stage of labor. Journal of Obstetrics and Gynaecology of India 2006;56(4):396-8.
99. Xu 2003 Xu H. Misoprostol on preventing postpartum bleeding in cesarean. Hebei Medicine 2003;9(9):806-7.
100. Yuan 2003 Yuan YM, Liu CF. Clinical observation of treatment for 60 cases of postpartum hemorrhage with misoprostol tablets combined with jiashenshenghuatang. Chinese Clinical New Medicine 2003;3(10):902.
101. Amant 2001 Amant F. Themisoprostol third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. [letter]. BJOG: an international journal of obstetrics and gynaecology 2001;108:338.
102. Andolina 1999 Andolina K, Daly S, Roberts N, Tolosa J, Wapner R. Objective measurement of blood loss at delivery: is it more than a guess?. American Journal of Obstetrics and Gynecology 1999;180:S69.
103. Carroli 2001 Carroli G. RHL practical aspects: oxytocin or oxytocin+ergot alkaloids in active management of the third stage of labour. The WHO Reproductive Health Library. Oxford: Update Software. WHO/RHR/01.6 2001.
104. Chong 1997 Chong YS, Chua S, Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstetrics & Gynecology 1997;90:703.
105. Cotter 2001 Cotter A, Ness A, Tolosa J. Prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2001, Issue 4.Art. No.: CD001808. DOI:10.1002/14651858.CD001808.
106. El-Refaey 1997 El-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of misoprostol in the prevention of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 1997;104:336-9.
107. Fawcus 1995 Fawcus S, Mbizvo MT, Lindmark G, Nystrom L (Maternal Mortality Study Group). A community based investigation of causes of maternal mortality in rural and urban Zimbabwe. Central African Journal of Medicine 1997;41:105-13.
108. Gibbens 1972 Gibbens D, Boyd NRH, Crocker S, Baumber S, Chard T. The circulating levels of oxytocin following intravenous and intramuscular administration of syntometrine. Journal of Obstetrics and Gynaecology of the British Commonwealth 1972;79:644-6.
109. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. In: The Cochrane Library, Issue 2, 2005. Chichester, UK: John Wiley & Sons, Ltd.
110. Hogerzeil 1996 Hogerzeil HV, Walker GJA. Instability of (methyl)ergometrine in tropical climates: an overview. European Journal of Obsterics & Gynecology and Reproductive Biology 1996;69:25-9.
111. Khan 2006 Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes ofmaternal death: a systematic review. Lancet 2006;367:1066-74.
112. McDonald 2004 McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD000201. DOI:10.1002/14651858.CD000201.pub2.
113. PATH 2001 PATH. Oxytocin in pre-filled Uniject TM injection devices for management of third stage of labour: an introductory trial in Lombok, Indonesia. Final report to Program for Appropriate Technology in Health (PATH), Seattle, Washington, USA, May 2001. PATH, 2001.
114. Prendiville 2000 Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database of Systematic Reviews 2000, Issue 3.Art. No.: CD000007. DOI:10.1002/ 14651858.CD000007.
115. WHO 1994 de Groot ANJA, Vree TB, Hogerzeil HV, Walker GJA. Stability of oral oxytocics in tropical climates (WHO/DAP/94.13). Geneva:World Health Organization, 1994.
116. Zieman 1997 Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD, Zieman M, et al.Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics & Gynecology 1997;90:88-92.
117. CDSR 1997 Gülmezoglu AM. Prostaglandins in third stage of labour. The Cochrane Library 1997, Issue 3.
118. CDSR 1998 Gülmezoglu AM. Prostaglandins in third stage of labour. The Cochrane Library 1998, Issue 4.
119. CDSR 2000 Gülmezoglu AM. Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). The Cochrane Library 2000, Issue 4.
120. CDSR 2002 Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage (Cochrane Review). The Cochrane Library 2002, Issue 2.
121. CDSR 2003 Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database of Systematic Reviews 2003, Issue 4.Art. No.: CD000494. DOI:10.1002/14651858. CD000494.
122. CDSR 2004 Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD000494. DOI:10.1002/14651858. CD000494.pub2.